SCHEMBL12038635

CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)C(C)NC(=O)C(CCCCNC(=O)COCCOCCNC(=O)CCN1C(=O)C=CC1=O)NC(=O)[C@@H]1CCCN1C(=O)C(C)NC(=O)[C@H](CC(C)C)NC(=O)C(CCC(N)=O)NC(=O)[C@@H](NC(=O)C(NC(=O)[C@H](CCCNC(=N)N)NC(=O)C(Cc1ccccc1)NC(=O)C(CCCCNNC(Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)NC(CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)NC(C=O)CO)[C@@H](C)O)N[C@@H](CO)C(=O)C(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)C(CCC(=O)O)NC(=O)[C@H](CO)NC(=O)C(Cc1ccccc1)NN)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)NC(CCC(=O)O)C(N)=O

nearest known ligand 0.55

Predicted protein targets (top 10)

	gene	UniProt	supporting neighbours	confidence
▸	KDM1A	O60341	1/20	0.55

▸	MAOB	P27338	1/20	0.55

▸	KDM5A	P29375	1/20	0.55

▸	KDM1B	Q8NB78	1/20	0.55

▸	TFPI	P10646	2/20	0.52

▸	RAMP3	O60896	2/20	0.52

▸	CALCR	P30988	2/20	0.52

▸	GLP1R	P43220	14/20	0.52

▸	GCGR	P47871	8/20	0.52

▸	GIPR	P48546	7/20	0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL12038577	0.88	NPY2R (0.60)	KDM1ATFPICALCR
SCHEMBL12038559	0.87	NPY2R (0.59)	KDM1ATFPI
SCHEMBL25544142	0.87	NPY2R (0.59)	KDM1ATFPI
SCHEMBL12038621	0.86	NPY2R (0.59)	KDM1AMAOBKDM5AKDM1BTFPI
SCHEMBL12038596	0.86	NPY2R (0.61)	KDM1ATFPICALCR
SCHEMBL12038668	0.85	NPY2R (0.59)	KDM1ATFPICALCR
SCHEMBL12038607	0.84	EED (0.52)	KDM1ATFPIGCGR
SCHEMBL29361579	0.83	NPY2R (0.56)	KDM1AMAOBKDM5AKDM1BTFPI
SCHEMBL12038587	0.83	NPY2R (0.48)	KDM1ATFPI
SCHEMBL12038572	0.82	NPY2R (0.52)	KDM1ATFPICALCRGLP1RGCGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20110318373-A1	IMMUNOSUPPRESSION MODULATING COMPOUNDS	AURIGENE DISCOVERY TECHNOLOGIES LIMITED (IN)	2011-12-29	—	—	US	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-20110318373-A1	IMMUNOSUPPRESSION MODULATING COMPOUNDS	CD274, PDCD1, PDCD1LG2	KDM1A 1624/4885MAOB 4281/4885KDM5A 1830/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.